Philadelphia, PA, United States of America

Gavin Ellis

This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: University of Pennsylvania. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Gavin Ellis in Transplantation Science

Introduction

Gavin Ellis is an accomplished inventor based in Philadelphia, PA. He has made significant contributions to the field of transplantation science, particularly in methods to protect transplanted tissue from rejection. His innovative work has the potential to improve the outcomes of transplant procedures and enhance patient care.

Latest Patents

Gavin Ellis holds a patent for "Methods to protect transplanted tissue from rejection." This invention includes compositions and methods for an HLA-A2 specific chimeric antigen receptor (CAR). In certain embodiments, the HLA-A2 specific CAR is expressed on a T regulatory cell. This innovative approach aims to protect transplanted tissue from rejection, showcasing Ellis's commitment to advancing medical technology.

Career Highlights

Gavin Ellis is affiliated with the University of Pennsylvania, where he continues to engage in groundbreaking research. His work at this prestigious institution allows him to collaborate with leading experts in the field and contribute to significant advancements in transplantation science.

Collaborations

Gavin Ellis has worked alongside notable colleagues, including James L. Riley. Their collaboration has fostered an environment of innovation and discovery, further enhancing the impact of their research.

Conclusion

Gavin Ellis's contributions to transplantation science through his innovative patent demonstrate his dedication to improving medical outcomes. His work at the University of Pennsylvania and collaborations with esteemed colleagues position him as a key figure in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…